-----------------------------------------------------------
Dr. Ruth Report 5/3/26
Respiratory illnesses have finally decreased significantly overall.
RSV activity has peaked in most regions of the country and is decreasing.
Flu activity continues to decrease. As of May 2, Influenza B is still high in many parts of the country per WastewaterSCAN. In Palo Alto, Influenza B is still moderately high.
COVID activity is low in most parts of the United States.
The CDC reported that Nebraska had HIGH levels of SARS-CoV-2 in wastewater on 4/25/26, but there were only 2 sites reporting and they are right next to each other- one of which is VERY HIGH and the other of which is reported as VERY LOW.
As of 5/2/26, Omaha has LOW levels of SARS-CoV-2 in wastewater according to WastewaterSCAN.
Wastewater SCAN: https://data.wastewaterscan.org/
Regional wastewater levels for COVID, RSV, Flu A, Flu B.
Influenza B is still high in wastewater in many parts of the country.
4/29/26 Nature: Macrophage-derived MBL restrains coronavirus-induced pulmonary inflammation by modulating metabolic regulator PKM2-mediated NLRP3 activation https://buff.ly/IufGvv1
Southern Medical University (Guangzhou) researchers find that mannose-binding lectin (MBL), produced by macrophages, curbs coronavirus lung inflammation by binding directly to the metabolic enzyme PKM2. This blocks a structural shift in PKM2 that would otherwise drive NLRP3 inflammasome overactivation, reducing caspase-1 cleavage, IL-1β release, and lung tissue damage.
4/28/26 Nature: Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients https://buff.ly/UuvYd8h
Scientists used single-cell RNA sequencing to study immune responses in COVID patients, recovered patients, and healthy people. They found that genes and environmental factors interact to shape the body’s response to infection. About 17% of immune-related genetic regions changed activity during infection, especially in monocytes through interferon and metabolic pathways, helping explain why COVID may affect people differently.
4/29/26 BMC Infectious Diseases: Association of race, ethnicity, and pediatric long COVID and MIS-C: a systematic review and meta-analysis https://buff.ly/mPAApD2
UTHealth Houston School of Public Health reviewed 31 studies and found non-Hispanic Black children faced 2.37 times higher odds of MIS-C and 89% higher odds of ICU admission than non-Hispanic White children. Hispanic children showed lower severe MIS-C risk but higher overall incidence, while Black children in UK cohorts faced more than 16 times the odds of PIMS-TS, underscoring structural healthcare inequities.
4/28/26 Nature Structural & Molecular Biology: TMPRSS2-mediated coronavirus spike activation and inhibition https://buff.ly/BXfvOZx
University of Washington (Veesler lab) researchers show that TMPRSS2 cleaves the SARS-CoV-2 spike only after ACE2 binding drives it into the early fusion intermediate conformation, exposing the S2 prime site at R815 and triggering membrane fusion. Antibodies targeting this site block TMPRSS2 access and SARS-CoV-2 viral infection. The team computationally designed a stabilized version of this as a vaccine candidate.
4/27/26 Journal of Virology: SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir https://buff.ly/4JRQpyf
Just as bacteria can become resistant to antibiotics, viruses can become resistant tot antiviral medications. Researchers find that two mutations in the SARS-CoV-2 main protease (T21I and E166A), selected under simnotrelvir pressure, confer mild to moderate resistance against simnotrelvir, nirmatrelvir, and ensitrelvir. Bofutrelvir retains strong activity against these variants due to its aldehyde warhead chemistry, and both simnotrelvir and bofutrelvir remained effective in mouse studies.
4/29/26 Nature: Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID https://buff.ly/ZASWfoq
This week, Nature had a review from an all-star team of Long COVID researchers looking at “current knowledge, gaps, and future directions for research, diagnosis, and treatment” of Long COVID. Faghy et al. reviewed Long COVID, which now affects over 400 million people and carries estimated annual economic costs exceeding $1 trillion. Symptoms spanning cognitive dysfunction, severe fatigue, and post-exertional malaise are likely driven by immune dysregulation, viral persistence, autonomic dysfunction, and microvascular damage, yet no validated diagnostic criteria or proven treatments currently exist.
From: https://www.nature.com/articles/s43856-025-01300-z/figures/1
Fig. 2: The role of viral persistence in Long COVID.
Mechanistic insight into the role of viral persistence across different systems and tissues in the context of Long COVID, image published by Chen et al.108.
From: https://www.nature.com/articles/s43856-025-01300-z/figures/3
5/1/26 Pilot and Feasibility Studies: An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID https://buff.ly/mLUFvK3
UK researchers will study a feasibility trial of “5-day intravenous treatment with Remdesivir for patients with Long COVID (LC). The treatment is already effective in the treatment of patients with acute severe cases of SARS-CoV-2. Remdesivir has an established safety profile.”
Of note, there are oral versions of Remdesivir like Obeldesivir (ODV) being developed. Obeldesivir is currently being tested in phase 3 trials for COVID treatment, but the drug may also be effective against filoviruses, including Marburg virus, Ebola virus, and Sudan virus (SUDV). If it is approved, I believe that it could be important to trial a longer course of Obeldesivir or another antiviral, in combination with either a monoclonal antibody or an immunomodulatory drug, to treat viral persistence, inflammation and immune system exhaustion in Long COVID.
4/10/26 Viruses: Integrative Insights into the Immunopathogenesis and Organ-Specific Immunological Mechanisms of Long COVID: A Narrative Review https://buff.ly/Bf1rVT4
In a lengthy review, Indian researchers looked at Long COVID mechanisms across organ systems and found that it may be driven by a multifactorial interplay of persistent viral reservoirs, chronic immune activation, autoimmunity, microvascular injury, and organ-specific inflammation. They noted that no single pathway dominates.
4/12/26 Frontiers in Immunology: Pathophysiological mechanisms of post-exertional malaise: an integrative analysis based on the metabolism-immune-neuro interaction model https://buff.ly/234D4ia
Chengdu University researchers reviewed how post-exertional malaise (PEM) may arise from a self-perpetuating loop of mitochondrial dysfunction, immune activation, and neuroinflammation. In people with underlying vulnerability from prior infection, physical or emotional exertion may act as a second hit that overwhelms adaptive repair, converting normal metabolic stress into escalating inflammatory injury and central fatigue seen in PEM.
Figure 1. The Two-Hit Model and Provocation Framework for Post-Exertional Malaise (PEM).
From: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full
4/27/26 Arthritis & Rheumatology: Differences in SARS‐CoV‐2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER‐Adult Cohort Study https://buff.ly/cSmABMv
Mass General Brigham researchers compared 210 patients with systemic autoimmune rheumatic diseases to 348 controls and found nearly 3x higher odds of detectable viral antigens at three months and over 6x higher nucleocapsid antigen positivity at six months. Unlike controls, antigen levels in the rheumatic disease group did not decline between those timepoints, implicating immunosuppressive medications as the likely driver.
4/30/26 J of Extracellular Vesicles: When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars‐Cov‐2‐Induced Neurodegeneration https://buff.ly/VuqtK6n
Dutch scientists propose that extracellular vesicles carrying SARS-CoV-2 proteins and dysregulated microRNAs can cross the blood-brain barrier and disrupt three pathways shared with Alzheimer’s and Parkinson’s disease: neurovascular integrity, metabolic homeostasis, and protein quality control. The authors position these vesicles as potential drivers of chronic neuroinflammation and neurodegeneration well after viral clearance.
4/27/26 Endocrine Reviews: Regulatory Cycles of Orexin and Glucagon-Like Peptide-1 in Post-Viral Syndromes https://buff.ly/fdOElIg
Philipps University Marburg (Germany) researchers review how disrupted orexin and GLP-1 signaling may connect the fatigue, sleep dysfunction, and metabolic abnormalities seen in Long COVID and ME/CFS. The review also examines GLP-1’s neuroprotective and anti-inflammatory roles and highlights GLP-1 receptor agonists and orexin-targeted drugs as promising treatment avenues for post-viral syndromes.
4/29/26 MedRxiV: Diagnostic Classification for Long Covid Patients identifying Persistent Virus and Hyperimmune Pathophysiologies https://buff.ly/0isHTah
University of Exeter researchers, using Attomarker‘s multiplex antibody platform in 159 Long COVID patients, identified that 62% of patients showed antibody patterns consistent with incomplete viral clearance and persistent infection, while about 12% displayed a hyperimmune profile. The findings support patient stratification toward targeted treatments.
4/29/26 NeuroImage: Decreased functional connectivity in post-COVID syndrome patients with high neuroinflammatory activity https://buff.ly/3GgGSxe
Amsterdam UMC researchers combined PET and MRI in 45 post-COVID patients finding that higher brain inflammation on PET was associated with weaker connectivity in brain networks governing attention and higher cognition (thinking). Thalamic and somatomotor network changes tracked with neurocognitive complaints, while brainstem connectivity changes tracked with neuroinflammatory activity.
4/29/26 Acta Neuropathologica: Pathogenic IgG from long COVID patients with neurological sequelae triggers sensitive but not cognitive impairments upon transfer into mice https://buff.ly/ULEZQQr
Belgian researchers purified IgG from 13 Long COVID patients with neurological symptoms and injected it into mice. The antibodies accumulated in dorsal root ganglia sensory neurons and produced transient mechanical and thermal pain hypersensitivity, with no effect on memory, anxiety, or depression, supporting autoantibody-mediated peripheral pain as one part of Long COVID.
1/26/26 Sensors & Diagnostics: Snapshot of long COVID in young adults: fast screening using electronic noses https://buff.ly/Jvk5KEB
A team from Mexico and Germany studied 78 university students with prior COVID infection and found 29.5% met WHO Delphi criteria for Long COVID despite normal lung function tests. They used an “electronic nose” to analyze exhaled breath volatile organic compounds (VOC) which distinguished Long COVID from controls with 97.4% accuracy, suggesting breath analysis as a rapid, noninvasive screening approach for Long COVID in younger populations.
4/16/26 Vaccines (Italy): Autoimmune Features of Post-COVID-19 Vaccination Syndrome and Their Impacts on the Renin–Angiotensin System https://buff.ly/VoTxgKZ
Verona and Milan researchers looked at post-COVID-19 vaccination syndrome (PACVS) and presented data from 17 patients showing autoantibodies to ACE2 and MAS1 receptors that may disrupt the renin-angiotensin system. Anti-ACE2 correlated significantly with skin symptoms and hypertension, while anti-MAS1 correlated with widespread burning pain, pointing to RAS dysregulation as a possible PACVS mechanism.
4/28/26 Annals of Family Medicine (Mayo Clinic): Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Before Specialist Evaluation https://buff.ly/WTYUESX
Mayo Clinic researchers reviewed records of 571 ME/CFS patients referred to specialty care between 2018 and 2022 and found that medications used most often before consultation targeted pain, sleep, and mood, while specialist-favored options like low dose naltrexone, aripiprazole, and pyridostigmine were rarely prescribed. Meanwhile, 72.2% of patients were using supplements to manage symptoms.
CDC Measles updates (on Wed.): https://www.cdc.gov/measles/data-research/index.html
As of April 30, 2026, 1,814 confirmed measles cases were reported in the United States in 2026.
“In the first 4 months of 2026, there have been 1,814 confirmed measles cases (& doubtless many more that were never confirmed). For context: That’s 79% of the total for the entirety of 2025 — but in 4 months, not 12.” -Helen Branswell
5/1/26 ABC: After nearly 1,000 cases, here’s how South Carolina officials beat back a measles outbreak https://buff.ly/5yMTC5w
The South Carolina measles outbreak that started in October 2025 has finally been declared over after a total of 997 confirmed measles cases, mostly in unvaccinated children. “Measles vaccinations [were] the most effective single containment tool,” Dr. James Harber… told ABC News. “And then to identify the index cases and their exposures and enforcing quarantine, and there’s that integrated public health and private sector collaboration. Those are the keys.”
Utah Department of Public Health (Measles): https://epi.utah.gov/measles-response/
In Utah, there have been 31 new measles cases reported to public health in the last 3 weeks, with 197 cases noted in 2025 and an additional 428 measles cases reported since the beginning of 2026.
4/30/26 NEJM Evidence: Detection of a Single Measles Infection Using Untargeted Ultra-Deep Metagenomic Sequencing of Wastewater in Cook County, Illinois https://buff.ly/JZuqfeI
Wastewater analysis can be powerful. Researchers at the University of Illinois at Chicago and the Illinois Department of Public Health detected a single measles infection in a Cook County wastewater system serving more than 1 million people, identifying just 43 matching reads out of nearly 1 billion sequenced. Genomic analysis confirmed the wastewater sequences matched a clinical isolate from an unvaccinated child, demonstrating the remarkable sensitivity of wastewater surveillance for infectious diseases.
John Hopkins US Measles Tracker: https://publichealth.jhu.edu/ivac/resources/us-measles-tracker
There were 64 cases of measles reported in the U.S. in the last 2 weeks.
5/1/26 Kristen Panthagani, MD, PhD: Did AI really beat ER doctors at ER triage? https://buff.ly/y0281DX
Great summary by Dr. Kristen Panthagani about the misleading new article from Science magazine (see below) that has the lay press saying that AI is better at diagnosing medical issues than ER doctors. The Science article had significant flaws including testing 2 internal medicine doctors and not ER doctors, making the goal of the study to find a final diagnosis and not to avoid emergencies, and the AI was fed all of the work of the ER team without gleaning this itself.
4/30/26 Science: Performance of a large language model on the reasoning tasks of a physician https://buff.ly/vMVL3UZ
4/27/26 J Clinical Oncology: Safety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood Transplantation https://buff.ly/vvCJ55q
In a phase II trial, researchers at Fred Hutch Cancer Center treated 28 patients with leukemia or related blood cancers using a single umbilical cord blood transplant plus Dilanubicel, an expanded stem cell product from pooled cord blood donors. The treatment showed strong safety and effectiveness: 96% survived at least one year, with no severe graft-versus-host disease.
4/24/26 KFF Health News: A ‘Barbaric’ Problem in American Hospitals Is Only Getting Bigger https://buff.ly/lzNpqom
Emergency departments are so overwhelmed and hospitals are full that they “board” patients who are waiting to be admitted in the hallways of the ED for hours, days and even weeks. “In this limbo state, you’re technically admitted to the hospital, but still located in the physical domain of the ER. And the rules governing acceptable care and safety measures become much less clear.” This is subpar care and a public health catastrophe.
4/2/26 Cancer Immunology Research: Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15–Related Haplotypes https://buff.ly/1sXhkoG
Human leukocyte antigens (HLA) were analyzed in patients who developed pituitary and/or thyroid immune-related adverse events (irAE) after use of immune checkpoint inhibitor medications for cancer treatment. The frequency of the HLA-DRB1*15:01 and DRB1*15:02 haplotypes were found to be significantly higher in these patients. In the future, precision immunotherapy should include pretreatment testing of HLA haplotypes.
4/23/26 NY Times: New Gene Therapy Enables Children With a Rare Form of Deafness to Hear https://buff.ly/oikLsHF
“The Food and Drug Administration on Thursday approved a gene therapy that can cure a rare, inherited form of deafness. The treatment is the first to restore normal hearing in children who were born deaf…The maker of the therapy, Regeneron, plans to provide it free to any child who needs it.”
4/24/26 PBS: 988 hotline linked to thousands fewer youth suicide deaths since launch, study finds https://buff.ly/pkCS07V
Harvard Medical School researchers published in JAMA an analysis of national death certificate data from 1999 to 2024 and found suicide deaths among 15 to 34-year-olds ran 11% lower than projected in the first two and a half years after the 988 Suicide and Crisis Lifeline launched in July 2022, representing roughly 4,400 fewer deaths than expected. States with the largest increases in call volume saw the steepest declines.
4/19/26 CNN: Photographer Steve Parke’s new book on Prince https://buff.ly/9zvdP2N
Photo: Steve Parke
4/29/26 People: Baby Born on Board Delta Flight Pictured with Mom Moments After Birth as EMT Shares New Delivery Details (Exclusive) https://buff.ly/I3KrgMD
Mom Ashley Blair unexpectedly gave birth on a Delta flight from Atlanta to Portland this week with the assistance of 2 EMTs on board. Baby Brielle arrived safely shortly before landing and the whole plane cheered when the baby cried to announce her arrival.
EMTs Kaarin Powell and Tina Fritz, with Ashley Blair and her newborn baby Brielle.
I’ll be taking next week off from the newsletter.
Have a good week,
Ruth Ann Crystal MD















